Nano T-Sailing
Nano T-Sailing is a University of Tokushima spin-off that develops 3D cell culture substrates using bacterial cellulose nanofiber technology and anti-PEG antibody detection kits, selling primarily to Japanese pharmaceutical, biotech, and academic research customers through direct sales and a Miki Sangyo distribution partnership.
- Company typePrivate
- Founded2020
- HeadquartersTokushima, Japan
- Headcount—
- GTM typeB2B
- OfferingHardware or Manufacturing
What Nano T-Sailing does
Nano T-Sailing合同会社 (Nano T-Sailing LLC) is a Japanese biotechnology company founded on July 1, 2020, and headquartered at the University of Tokushima Venture Business Laboratory in Tokushima City. The company develops and manufactures two related product lines: three-dimensional cell culture substrates and antibody-based detection products, all positioned for research use only. Its core technology is a bacterial cellulose nanofiber (NFBC) synthesized by Acetobacter spp. using sugar beet from Hokkaido as the raw material, which serves as a substrate enabling spheroid formation of multiple cell types including HepG2 liver cancer cells, MCF-7 and 4T1 breast cancer lines, MKN45 gastric cancer, B16 melanoma, and human iPS cells without specialized reagents or equipment. The lead product, 3D-NanoFibGrow-I, is supplied in 10 mL, 25 mL, and 50 mL formats priced at 19,800 to 59,800 yen, and is documented to increase CYP enzyme activity relevant to drug metabolism studies.
The second product line addresses anti-PEG (polyethylene glycol) antibody detection through proprietary hybridoma-derived monoclonal antibodies. The company sells Anti-PEG IgG and IgM ELISA kits (50,000 yen each, 96-well format) for monitoring patients treated with PEGylated drugs and detecting anti-PEG antibodies linked to treatment failure or anaphylaxis-like reactions, plus standalone purified mouse anti-PEG IgG (HIK-G11) and IgM (HIK-M11) antibodies launched in November 2024, priced from 48,000 to 198,000 yen. The business also lists contract antibody manufacturing, peptide synthesis, and liposome-related services as part of its offering, leveraging the same hybridoma and bio-conjugation capabilities.
Commercially, Nano T-Sailing operates a dual-channel model: direct sales via downloadable order forms submitted through its Japanese-and-English website, and a core distribution partnership with Miki Sangyo Co., Ltd., which organizes exhibition booths at Japanese academic conferences including the Japan Society for Pharmacokinetics annual meetings. The company is founder-led by Representative Partner Hideki Ando, who holds a Doctor of Pharmaceutical Sciences from the University of Shizuoka and previously held project assistant professor and assistant professor positions at the University of Tokushima and Yamaguchi University. The firm was established with capital stock of 1.5 million yen, has no disclosed external institutional investment, and currently serves customers only in Japan.
Nano T-Sailing firmographics
Firmographics- Name
- Nano T-Sailing
- Legal name
- Nano T-Sailing合同会社
- Website
- https://nano-t-s.co.jp
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Short description
- Nano T-Sailing is a University of Tokushima spin-off that develops 3D cell culture substrates using bacterial cellulose nanofiber technology and anti-PEG antibody detection kits, selling primarily to Japanese pharmaceutical, biotech, and academic research customers through direct sales and a Miki Sangyo distribution partnership.
- Ownership category
- akta.pro rank
Nano T-Sailing industry classification
Industry- Product category
- Biotechnology Research Reagents
- NAICS
- Resin, Synthetic Rubber, and Artificial and Synthetic Fibers and Filaments Manufacturing (3252), Pulp Mills (32211), Research and Development in Nanotechnology (541713)
- SIC
- Broadwoven Fabric Mills, Man Made Fiber & Silk (2221), Pulp Mills (2611)
- akta.pro primary industry
- Compostable & Bio-Based Packaging (PLA/PHA, Starch Blends, Cellulose Films) (IMALAMAB)
- akta.pro secondary industries
- Nanocellulose & Cellulose Derivatives (CNC/CNF, MCC, ethers/esters) (IMAMALAD), Specialty Pulp (Microfibrillated/Nanocellulose, Filter/Technical Grades) (IMAMADAE), Microbiome Manufacturing, Formulation & Delivery Technologies (encapsulation, spores, oral delivery) (HLAAAFAJ)
Keywords
Where Nano T-Sailing is headquartered
LocationHeadquarters
- HQ city
- Tokushima
- HQ country
- Japan
- HQ region
- Asia
Offices1 record
Markets served
Nano T-Sailing business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales, Others
Revenue model
- 3D Cell Culture Substrate Sales: Sale of 3D-NanoFibGrow-I products in various sizes (10mL, 25mL, 50mL) for research and drug development applications.
- Anti-PEG Antibody Detection Kit Sales: Sale of ELISA kits for detecting anti-PEG antibodies (IgG and IgM) along with supporting reagents like blocking/dilution solution and wash buffer.
- Antibody Reagent Sales: Sale of purified anti-PEG IgG and IgM monoclonal antibodies in various volumes (0.1mL, 0.5mL) for research applications.
- Contract Antibody Manufacturing: Contract manufacturing of antibodies as part of their business description.
- Peptide Synthesis and Sales: Synthesis and sale of peptides and their derivatives.
- Liposome-related Services: Liposome-related contract services.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | 3D-NanoFibGrow-I (10 mL) |
| Unit Pricing | Pay-as-you-go | 3D-NanoFibGrow-I (25 mL) |
| Unit Pricing | Pay-as-you-go | 3D-NanoFibGrow-I (50 mL) |
| Unit Pricing | Pay-as-you-go | Anti-PEG IgM ELISA Kit |
| Unit Pricing | Pay-as-you-go | Anti-PEG IgG ELISA Kit |
| Unit Pricing | Pay-as-you-go | Blocking/Dilution Solution |
| Unit Pricing | Pay-as-you-go | 20x Wash Solution |
| Unit Pricing | Pay-as-you-go | Mouse Anti-PEG IgM Antibody (0.1mL) |
| Unit Pricing | Pay-as-you-go | Mouse Anti-PEG IgM Antibody (0.5mL) |
| Unit Pricing | Pay-as-you-go | Mouse Anti-PEG IgG Antibody (0.1mL) |
| Unit Pricing | Pay-as-you-go | Mouse Anti-PEG IgG Antibody (0.5mL) |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels4 records
Nano T-Sailing product offering
Product offeringCore offering
Nano T-Sailing develops and manufactures three-dimensional cell culture substrates (3D-NanoFibGrow-I) made from bacterial cellulose nanofibers synthesized by Acetobacter spp. using Hokkaido sugar beet, enabling spheroid formation of multiple cell types. The company also develops and sells anti-PEG antibody ELISA detection kits and purified monoclonal anti-PEG IgG/IgM antibody reagents for research and PEG immunogenicity monitoring applications.
Product overview
Nano T-Sailing offers a product portfolio centered on three-dimensional cell culture substrates and antibody-related products. The core product is 3D-NanoFibGrow-I, a bacterial cellulose nanofiber-based substrate for spheroid cell culture used in drug metabolism research. Complementing this are Anti-PEG IgG and IgM ELISA detection kits for identifying anti-PEG antibodies in clinical specimens, along with corresponding purified monoclonal antibody reagents (HIK-G11 and HIK-M11) sold separately. Accessory reagents (blocking/dilution solution and wash solution) support the ELISA workflow.
Differentiator
Problem solved
Functional benefit
Products and services
- 3D-NanoFibGrow-I Cell Culture Substrate Three-dimensional cell culture substrate made from bacterial cellulose nanofibers synthesized by Acetobacter spp. using Hokkaido sugar beet as raw material. Enables spheroid formation of HepG2, iPS, and multiple cancer cell lines using a simple two-step room-temperature protocol without special reagents or equipment, and supports increased CYP enzyme activity for drug metabolism studies. Sold in 10 mL, 25 mL, and 50 mL sizes for research and drug development applications.
- Anti-PEG IgG ELISA Kit (NTS-002-G) 96-well sandwich ELISA kit for detecting anti-PEG IgG antibodies in serum using proprietary monoclonal antibodies purified from hybridomas. Used by clinical research and drug development organizations monitoring PEGylated drug efficacy and identifying anti-PEG antibody-mediated treatment failure or anaphylaxis-like reactions.
- Anti-PEG IgM ELISA Kit (NTS-002-M) 96-well sandwich ELISA kit for detecting anti-PEG IgM antibodies in serum using proprietary monoclonal antibodies purified from hybridomas. Used by clinical research and drug development organizations monitoring PEGylated drug efficacy and identifying anti-PEG antibody-mediated treatment failure or anaphylaxis-like reactions.
- Mouse Anti-PEG IgG Antibody (HIK-G11, NTS-002-G) Purified mouse monoclonal anti-PEG IgG antibody (isotype IgG), purified using a Protein G column, supplied in PBS with 50% glycerol at 0.5 mg/mL, sold in 0.1 mL and 0.5 mL volumes for research use.
- Mouse Anti-PEG IgM Antibody (HIK-M11, NTS-002-M) Purified mouse monoclonal anti-PEG IgM antibody (isotype IgM), purified using a Protein L column, supplied in PBS with 50% glycerol at 0.5 mg/mL, sold in 0.1 mL and 0.5 mL volumes for research use.
- Contract Antibody Manufacturing Service Contract manufacturing of antibodies provided as part of Nano T-Sailing's antibody-related business, leveraging the company's hybridoma and protein purification capabilities.
- Peptide Synthesis and Sales Service Custom synthesis and sale of peptides and peptide derivatives for research customers, leveraging the company's biochemical production capabilities.
- Liposome-Related Contract Service Liposome-related contract services provided as part of the company's antibody-related and broader biotechnology business.
Quantifiable outcome
- Increased activity of multiple CYP molecular species in HepG2 spheroids compared to 2D culture
- +2 more outcomes
Companies that use Nano T-Sailing
Customer profileSegments3 records
Ideal customer profiles3 records
Nano T-Sailing technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Nano T-Sailing partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Miki Sangyo Co., Ltd. (三木産業株式会社)coreMiki Sangyo organizes exhibition booths at academic conferences (such as the Japan Society for Xenobiotics 38th and 40th Annual Meetings) where Nano T-Sailing's 3D-NanoFibGrow-I products are introduced, demonstrated, and sample work is conducted.
Scale indicators2 records
Recent moves7 records
Expansion highlights5 records
Nano T-Sailing competitors and assessment
Company assessmentBroad incumbents
- Abcam: Major antibody supplier serving research markets globally with a broad monoclonal antibody catalog. Comparable to Nano T-Sailing's antibody product line, though Abcam operates at much larger scale with broader mAb offerings.
- Thermo Fisher Scientific: Major life science tools company offering Gibco cell culture media, Nunc plates, and 3D culture products. Competes broadly with Nano T-Sailing across the cell culture workflow with a vastly larger product portfolio and global distribution.
- Lonza: Major cell culture media and bioprocessing supplier serving pharma and biotech customers globally. Competes with Nano T-Sailing in the cell culture segment though Lonza operates at much larger scale with broader offerings.
- Merck KGaA: Life science division (MilliporeSigma) offers cell culture reagents, scaffolds, and 3D culture products. Competes broadly in the cell culture space with Nano T-Sailing and serves similar pharmaceutical and academic research customers.
Direct peers
- STEMCELL Technologies: Specializes in cell culture media, reagents, and 3D culture tools including organoid and spheroid systems. Directly comparable to Nano T-Sailing's 3D cell culture substrate offering for research and drug discovery applications.
- Creative Biolabs: Custom antibody production and contract research services including mAb development. Directly comparable to Nano T-Sailing's contract antibody manufacturing and antibody reagent offerings for research customers.
- Corning: Corning Life Sciences is a leading manufacturer of 3D cell culture substrates including Matrigel and Corning spheroid microplates. Directly competes with Nano T-Sailing's 3D-NanoFibGrow-I in the 3D cell culture and spheroid formation market.
Emerging players
- CelluForce: Canadian nanocellulose producer focused on industrial applications of cellulose nanocrystals. Comparable to Nano T-Sailing on the cellulose nanofiber technology base, though CelluForce's focus is industrial rather than biomedical.
Regional players
- Takara Bio: Japanese life science tools company offering cell culture reagents, antibodies, and molecular biology products. Regional competitor serving Japanese research markets with overlapping customer base to Nano T-Sailing.
- FUJIFILM Wako Pure Chemical: Japanese reagents and chemicals supplier for life science research, including cell culture and antibody products. Comparable to Nano T-Sailing as a Japanese regional supplier serving academic and pharma research customers.
Market position
Strengths5 records
Weaknesses6 records
Competitive moat3 records
Key risks7 records
Key highlights7 records
Customer concentration
Nano T-Sailing financial estimates
Financial estimateRevenue estimate
Valuation estimate
Nano T-Sailing leadership team
Management profileNumber of profiles
Profiles1 record
Nano T-Sailing funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Nano T-Sailing M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Nano T-Sailing
What does Nano T-Sailing do?
Nano T-Sailing develops and manufactures three-dimensional cell culture substrates (3D-NanoFibGrow-I) made from bacterial cellulose nanofibers synthesized by Acetobacter spp. using Hokkaido sugar beet, enabling spheroid formation of multiple cell types. The company also develops and sells anti-PEG antibody ELISA detection kits and purified monoclonal anti-PEG IgG/IgM antibody reagents for research and PEG immunogenicity monitoring applications.
Is Nano T-Sailing a public or private company?
Nano T-Sailing is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Nano T-Sailing founded?
Nano T-Sailing was founded in 2020.
Where is Nano T-Sailing based?
Nano T-Sailing is headquartered in Tokushima, Japan, in the Asia region.
How does Nano T-Sailing make money?
Six revenue lines are on record. 3D Cell Culture Substrate Sales are the primary driver. The others are anti-PEG Antibody Detection Kit Sales, antibody Reagent Sales, contract Antibody Manufacturing, peptide Synthesis and Sales and liposome-related Services.
Who are Nano T-Sailing's main competitors?
Broad incumbents on record are Abcam, Thermo Fisher Scientific, Lonza and Merck KGaA. Direct peers are STEMCELL Technologies, Creative Biolabs and Corning. CelluForce is listed as an emerging player. Regional players are Takara Bio and FUJIFILM Wako Pure Chemical.
Does Nano T-Sailing have an API?
No public API is recorded for Nano T-Sailing.
What industry is Nano T-Sailing in?
Nano T-Sailing's product category is Biotechnology Research Reagents. Its primary akta.pro industry code is IMALAMAB, Compostable & Bio-Based Packaging (PLA/PHA, Starch Blends, Cellulose Films), with a secondary code of IMAMALAD, Nanocellulose & Cellulose Derivatives (CNC/CNF, MCC, ethers/esters). Its NAICS code is 3252 and its SIC code is 2221.